Anika Therapeutics, Inc.: 10-Q filed 2012-08-07

Name: Anika Therapeutics, Inc.: 10-Q filed 2012-08-07
Creator: Anika Therapeutics, Inc.

What Anika Therapeutics, Inc. reported in its quarterly report filed 2012-08-07 (fiscal Q2 2012): 42 published measures, 111 facts as tagged in accession 0001157523-12-004339.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-08-07
Fiscal period: fiscal Q2 2012
Accession: 0001157523-12-004339 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Anika Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-06-30	136,375,599	USD
At 2011-12-31	132,844,434	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	100,748,453	USD
At 2011-12-31	94,762,778	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-06-30	37,909,608	USD
At 2011-12-31	35,777,222	USD
At 2011-06-30	26,829,029	USD
At 2010-12-31	28,201,932	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	3,736,868	USD	91
2012-01-01 to 2012-06-30	5,648,987	USD	182
2011-04-01 to 2011-06-30	2,282,641	USD	91
2011-01-01 to 2011-06-30	2,607,052	USD	181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	3,534,789	USD	182
2011-01-01 to 2011-06-30	-110,499	USD	181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	1,145,493	USD	182
2011-01-01 to 2011-06-30	655,784	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-252,642	USD	182
2011-01-01 to 2011-06-30	-648,233	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-1,145,493	USD	182
2011-01-01 to 2011-06-30	-655,784	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-06-30	39,901,208	USD
At 2011-12-31	34,252,221	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	13,262,023	shares	91
2012-01-01 to 2012-06-30	13,212,424	shares	182
2011-04-01 to 2011-06-30	12,725,216	shares	91
2011-01-01 to 2011-06-30	12,707,143	shares	181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	14,443,794	shares	91
2012-01-01 to 2012-06-30	14,302,439	shares	182
2011-04-01 to 2011-06-30	13,739,836	shares	91
2011-01-01 to 2011-06-30	13,741,337	shares	181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	0.28	USD/shares	91
2012-01-01 to 2012-06-30	0.43	USD/shares	182
2011-04-01 to 2011-06-30	0.18	USD/shares	91
2011-01-01 to 2011-06-30	0.21	USD/shares	181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	0.26	USD/shares	91
2012-01-01 to 2012-06-30	0.39	USD/shares	182
2011-04-01 to 2011-06-30	0.17	USD/shares	91
2011-01-01 to 2011-06-30	0.19	USD/shares	181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	2,347,873	USD	91
2012-01-01 to 2012-06-30	3,447,611	USD	182
2011-04-01 to 2011-06-30	1,349,655	USD	91
2011-01-01 to 2011-06-30	1,541,001	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-06-30	36,421,107	USD
At 2011-12-31	36,469,878	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	633,073	USD	182
2011-01-01 to 2011-06-30	582,307	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	6,133,870	USD	91
2012-01-01 to 2012-06-30	9,196,930	USD	182
2011-04-01 to 2011-06-30	3,677,577	USD	91
2011-01-01 to 2011-06-30	4,234,255	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-06-30	69,599,015	USD
At 2011-12-31	64,137,544	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	15,214,063	USD
At 2011-12-31	14,538,423	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-06-30	3,941,436	USD
At 2011-12-31	4,299,680	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit
At 2012-06-30	8,627,518	USD
At 2012-03-31	9,150,273	USD
At 2011-12-31	8,883,407	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-06-30	17,694,097	USD
At 2011-12-31	17,307,786	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-06-30	10,776,788	USD
At 2011-12-31	7,302,483	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	4,108,503	USD	91
2012-01-01 to 2012-06-30	7,459,519	USD	182
2011-04-01 to 2011-06-30	4,233,316	USD	91
2011-01-01 to 2011-06-30	8,277,090	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	1,298,170	USD	91
2012-01-01 to 2012-06-30	2,831,273	USD	182
2011-04-01 to 2011-06-30	1,574,155	USD	91
2011-01-01 to 2011-06-30	3,106,820	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-06-30	13,765,996	shares
At 2011-12-31	13,630,607	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-06-30	64,620,510	USD
At 2011-12-31	63,441,433	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2012-06-30	10,400,000	USD
At 2011-12-31	12,800,000	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2012-06-30	51,920,745	USD
At 2011-12-31	50,850,630	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2012-06-30	15,499,638	USD
At 2011-12-31	14,380,752	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2012-06-30	21,506,474	USD
At 2011-12-31	23,148,563	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-06-30	1,535,140	USD
At 2011-12-31	1,548,652	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-06-30	4,275,574	USD
At 2011-12-31	5,321,594	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2012-06-30	1,299,596	USD
At 2011-12-31	1,831,127	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	6,084,741	USD	91
2012-01-01 to 2012-06-30	9,096,598	USD	182
2011-04-01 to 2011-06-30	3,632,296	USD	91
2011-01-01 to 2011-06-30	4,148,053	USD	181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	2,136,664	USD	91
2012-01-01 to 2012-06-30	4,805,244	USD	182
2011-04-01 to 2011-06-30	2,877,841	USD	91
2011-01-01 to 2011-06-30	4,951,914	USD	181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	2,182,129	USD	182
2011-01-01 to 2011-06-30	1,940,827	USD	181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	506,706	USD	91
2012-01-01 to 2012-06-30	1,022,984	USD	182
2011-04-01 to 2011-06-30	544,776	USD	91
2011-01-01 to 2011-06-30	1,081,816	USD	181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	14,036	USD	182
2011-01-01 to 2011-06-30	828,703	USD	181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	892,265	USD	182
2011-01-01 to 2011-06-30	1,618,730	USD	181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	3,713,817	USD	182
2011-01-01 to 2011-06-30	536,642	USD	181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-01-01 to 2012-06-30	-170,035	USD	182
2011-01-01 to 2011-06-30	-2,642,810	USD	181

Inspect the source

Entity: Anika Therapeutics, Inc. / CIK 0000898437
Captured: 2026-09-20T05:04:56.960Z
SEC response SHA-256: f1da3290842851cfa646165073c3c5bf9c06212e35bc3d1892f2be77cae8b535

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000898437.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))